Paper Details

  1. Home
  2. Paper Details

New nucleoside analogues for chronic hepatitis B.

Author: HeijtinkR A, NiestersH G, SchalmS W, de ManR A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This study reviews the use of nucleoside analogues in the treatment of hepatitis B virus infections. Fialuridine was found to be effective but associated with severe mitochondrial dysfunction, while lamivudine and famciclovir were found to be effective and well-tolerated.
Paper Details　
Original Abstract of the Article :
In recent years, an in vitro system for screening nucleoside analogues against hepatitis B virus has yielded several compounds with a high therapeutic index. Phase I and II studies have also shown a potent in vivo antiviral effect of fialuridine and lamivudine in patients with chronic hepatitis B. T...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/7602078

データ提供：米国国立医学図書館（NLM）

Treating Chronic Hepatitis B: A Look at Nucleoside Analogues

Hepatitis B is a viral infection that can cause liver damage and inflammation. This study focuses on the use of nucleoside analogues, a class of antiviral drugs, in treating chronic hepatitis B. It's like searching for a powerful weapon to fight a persistent enemy, aiming to eradicate the virus and restore health.

The study highlights the potential of nucleoside analogues like lamivudine and famciclovir as effective treatments for chronic hepatitis B, demonstrating the ongoing advancements in antiviral therapies. It's like finding a new and potent antidote for a venomous snakebite, offering hope and relief to those affected.

Battling Hepatitis B: New Antiviral Strategies

This study highlights the promise of nucleoside analogues as effective treatments for chronic hepatitis B, providing a ray of hope for those battling this challenging disease.

Dr. Camel's Conclusion

This research highlights the progress made in developing effective antiviral treatments for chronic hepatitis B. It underscores the importance of continued research to develop even more potent and safer treatments, aiming to conquer this viral infection and improve the lives of those affected.

Date :
  1. Date Completed 1995-08-10
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

7602078

DOI: Digital Object Identifier

7602078

Related Literature

Article Analysis
・Side Effects of famciclovir
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.